Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

CYTR

CytRx (QB) (CYTR)

CytRx Corp (QB)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:CYTR
DateHeureSourceTitreSymboleSociété
26/06/202312h21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CYTRCytRx Corp (QB)
15/05/202312h29Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CYTRCytRx Corp (QB)
20/03/202311h08Edgar (US Regulatory)Annual Report (10-k)USOTC:CYTRCytRx Corp (QB)
14/02/202319h04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CYTRCytRx Corp (QB)
29/07/202201h03Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CYTRCytRx Corp (QB)
28/07/202222h06Edgar (US Regulatory)Amended Small Company Offering and Sale of Securities Without Registration (d/a)USOTC:CYTRCytRx Corp (QB)
16/06/202222h16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:CYTRCytRx Corp (QB)
16/06/202212h08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:CYTRCytRx Corp (QB)
03/06/202222h11Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:CYTRCytRx Corp (QB)
19/05/202223h04Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)USOTC:CYTRCytRx Corp (QB)
28/03/202212h05Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:CYTRCytRx Corp (QB)
25/03/202221h20Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:CYTRCytRx Corp (QB)
15/02/202212h30Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CYTRCytRx Corp (QB)
12/01/202216h59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CYTRCytRx Corp (QB)
04/08/202122h31Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:CYTRCytRx Corp (QB)
29/07/202112h08Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:CYTRCytRx Corp (QB)
13/07/202112h01Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:CYTRCytRx Corp (QB)
18/06/202118h07Dow Jones NewsOrphazyme, CytRx Shares Slide as FDA Rejects ArimoclomolUSOTC:CYTRCytRx Corp (QB)
22/04/202112h16Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:CYTRCytRx Corp (QB)
17/11/202012h11Edgar (US Regulatory)Amended Securities Registration (section 12(g)) (8-a12g/a)USOTC:CYTRCytRx Corp (QB)
23/10/202013h43Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:CYTRCytRx Corp (QB)
25/08/202016h12Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)USOTC:CYTRCytRx Corp (QB)
13/08/202015h30Edgar (US Regulatory)Proxy Statement - Non-management (definitive) (defn14a)USOTC:CYTRCytRx Corp (QB)
10/08/202014h56Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prrn14a)USOTC:CYTRCytRx Corp (QB)
10/08/202012h05Edgar (US Regulatory)Proxy Statment - Contested Solicitations (definitive) (defc14a)USOTC:CYTRCytRx Corp (QB)
20/07/202015h27Edgar (US Regulatory)Proxy Statement - Contested Solicitations (preliminary) (prec14a)USOTC:CYTRCytRx Corp (QB)
27/05/202012h06Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:CYTRCytRx Corp (QB)
 Showing the most relevant articles for your search:USOTC:CYTR

Dernières Valeurs Consultées

Delayed Upgrade Clock